Spots Global Cancer Trial Database for Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging

Official Title: A Phase III Prospective Multicenter Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging.

Study ID: NCT01004211

Conditions

Non Muscle Invasive Bladder Cancer

Interventions

Narrow band imaging transurethral resection

Standard transurethral resection

Study Description

Brief Summary: To date, fluorescence and narrow band imaging cystoscopy have been tested in many prospective within patient trials but only as an "add on" procedure. This results in a bias that does not allow to determine the real impact of such innovative technologies on bladder cancer management. Hereby we propose the first prospective randomized trial which compares narrow band imaging trans urethral resection as a stand alone procedure versus white light transurethral resection. The primary end point is to assess the recurrence rate of bladder cancer lesions with each treatment modality. The study is designed to disclose an inferior recurrence rate (estimated 10%) in the group treated by narrow band imaging transurethral resection respect to the control group, treated by standard transurethral resection.

Detailed Description: